[ Price : $8.95]
Roche and Genentech begin a Phase 1b/2 study of Erivedge in patients with relapsed/ refractory acute myelogenous leukemia and rela...[ Price : $8.95]
FDA approves Discovery Laboratories updated product specifications for Surfaxin (lucinactant) Intratracheal Suspension, indicated ...[ Price : $8.95]
FDA appears to be supporting approval of a CardioMEMS PMA for its Champion HF Monitoring System, an implantable pressure measureme...[ Price : $8.95]
FDA says the ongoing budget impasse and partial government shutdown should not affect its routine product review process for drug ...[ Price : $8.95]
Ben Venue Laboratories says the cost of complying with GMPs at its troubled Bedford, OH manufacturing facility has led it to cease...[ Price : $8.95]
FDA grants Cornerstone Pharmaceuticals an orphan drug designation for CPI-613, its lead altered energy metabolism-directed drug ca...[ Price : $8.95]
FDA clears a Bausch & Lomb 510(k) for its newest frequent replacement silicone hydrogel contact lenses made with MoistureSeal Tech...[ Price : $8.95]
Attorney John Smith looks at problems some companies will face in implementing FDAs new medical device tracking requirements.